key: cord-0906202-0t797vze
authors: Fomenko, Alexey; Weibel, Stephanie; Moezi, Helia; Menger, Kristina; Schmucker, Christine; Metzendorf, Maria‐Inti; Motschall, Edith; Falcone, Valeria; Huzly, Daniela; Panning, Marcus; Rücker, Gerta; Hengel, Hartmut
title: Assessing severe acute respiratory syndrome coronavirus 2 infectivity by reverse‐transcription polymerase chain reaction: A systematic review and meta‐analysis
date: 2022-04-02
journal: Rev Med Virol
DOI: 10.1002/rmv.2342
sha: b2ee8b02cf215c31600d3a739f373f7ecea6ca02
doc_id: 906202
cord_uid: 0t797vze

The cornerstone of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) detection is reverse‐transcription polymerase chain reaction (RT‐PCR) of viral RNA. As a surrogate assay SARS‐CoV‐2 RNA detection does not necessarily imply infectivity. Only virus isolation in permissive cell culture systems can indicate infectivity. Here, we review the evidence on RT‐PCR performance in detecting infectious SARS‐CoV‐2. We searched for any studies that used RT‐PCR and cell culture to determine infectious SARS‐CoV‐2 in respiratory samples. We assessed (i) diagnostic accuracy of RT‐PCR compared to cell culture as reference test, (ii) performed meta‐analysis of positive predictive values (PPV) and (iii) determined the virus isolation probabilities depending on cycle threshold (Ct) or log(10) genome copies/ml using logistic regression. We included 55 studies. There is substantial statistical and clinical heterogeneity. Seven studies were included for diagnostic accuracy. Sensitivity ranged from 90% to 99% and specificity from 29% to 92%. In meta‐analysis, the PPVs varied across subgroups with different sampling times after symptom onset, with 1% (95% confidence interval [CI], 0%–7%) in sampling beyond 10 days and 27% (CI, 19%–36%) to 46% (CI, 33%–60%) in subgroups that also included earlier samples. Estimates of virus isolation probability varied between 6% (CI, 0%–100%) and 50% (CI, 0%–100%) at a Ct value of 30 and between 0% (CI, 0%–22%) and 63% (CI, 0%–100%) at 5 log(10) genome copies/ml. Evidence on RT‐PCR performance in detecting infectious SARS‐CoV‐2 in respiratory samples was limited. Major limitations were heterogeneity and poor reporting. RT‐PCR and cell culture protocols need further standardisation.

included earlier samples. Estimates of virus isolation probability varied between 6% (CI, 0%-100%) and 50% (CI, 0%-100%) at a Ct value of 30 and between 0% (CI, 0%-22%) and 63% (CI, 0%-100%) at 5 log 10 genome copies/ml. Evidence on RT-PCR performance in detecting infectious SARS-CoV-2 in respiratory samples was limited. Major limitations were heterogeneity and poor reporting. RT-PCR and cell culture protocols need further standardisation. infection. 1 The detection of SARS-CoV-2 RNA by real-time RT-PCR is based on the amplification of specific gene targets. 1 In each amplification cycle, gene target regions are reversely transcribed until their fluorescence signals become detectable above a threshold level, the cycle threshold (Ct). The Ct value is inversely proportional to the amount of amplified DNA gene targets in the samples. However, the conversion of Ct values to genome copy number is not directly possible since for the interpolation of viral load the generation of a standard curve through amplification of a known concentration of a target is required. 2 As a nucleic acid-based detection method, RT-PCR detects RNA molecules derived from infectious and non-infectious virus particles, unpackaged RNA from infected cells and non-replicating RNA degradation products. Therefore, the duration of detectability of SARS-CoV-2 RNA in respiratory samples may differ substantially from the duration of virus isolation 3 We aimed to summarise available study data (i) to determine the performance of RT-PCR compared to cell culture in detecting infectious respiratory samples by assessing its diagnostic accuracy, (ii) to provide a meta-analysis of PPV, and (iii) to estimate virus isolation probability in relationship to Ct or log 10 genome copies/ml.

This study was conducted according to Preferred Reporting Items for a Systematic Review and Meta-analysis guidelines and was registered in PROSPERO (International Prospective Register of Systematic Reviews, CRD42021239149).

The literature was searched by an experienced information specialist (MIM) up to 19 April 2021 using three bibliographic databases:

Cochrane COVID-19 Study Register, Web of Science, and COVID-19

Open Access Project Living Evidence on COVID-19. Details of the search strategies are available as supplementary material S1. References of included studies were screened to identify additional records. No language restrictions were applied.

Studies that met the following criteria were included in this systematic review:

Types of studies: Any study design (diagnostic test accuracy (DTA) studies, case series, cohort studies, cross-sectional studies) was eligible for inclusion, provided that the study performed simultaneous RT-PCR and cell culture on respiratory samples to assess infectivity. In-vitro, in-silico, medical intervention, animal studies and studies with less than 5 participants were excluded. Peer-reviewed and preprint studies not otherwise published were included.

Participants: Participants of any gender, ethnicity, age with suspected or known SARS-CoV-2 infection.

Reference standard: Virus isolation with any permissive cell line was regarded as reference test.

Target condition: Detection of infectious respiratory specimens.

Outcomes: Sensitivity and specificity, PPV, means of Ct values or log 10 genome copies/ml in cell culture positive and negative samples, cell culture result and corresponding Ct value or log 10 genome copies/ml.

Search results were deduplicated in EndNoteTM X8 and imported into the web-based screening software Rayyan (www.rayyan.ai/).

Screening of titles and abstracts of retrieved records was performed to assess eligibility, and relevant articles were read in full text.

The following information from each included study was extracted: first author name, study design, publication date, country, RT-PCR assay details, cell culture details, TP, FP, false negative (FN), and true negative (TN) values, specimen types, symptom onset to test time, gene target, means of Ct and log 10 genome copies/ml and their upper bound of virus isolation. Genome copies/ml were converted to log 10 genome copies/ml (S2 represents a full list of extracted data items). In the case of multiple or overlapping publications, the study with the most recent date or the largest data set was extracted.

Study quality was evaluated using the Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2). 5 The QUADAS 2 tool was used for studies reporting sufficient data to create a 2 � 2 table (to derive diagnostic accuracy). As most of the studies did not intend to assess diagnostic accuracy of RT-PCR compared to cell culture as reference standard a modified QUADAS 2 tool was created (S3 and S4).

At least two reviewers (AF, HM, KM) independently selected the literature using Rayyan's blind-mode, extracted data and evaluated study quality.

Any disagreement was resolved by consultation with the third investigator (HH). Where necessary we contacted study authors for additional information.

All statistical analyses were performed using the open-source software R (Version 4.1.0). 6 

We calculated the accuracy measurements using TP, FP, FN, and TN values. Chi-square test was performed to test for equality of accuracy measurements. Heterogeneity was assessed visually by forest plots and receiver operating characteristics (ROC) ellipses.

Plots were generated using the mada package (version 0.5.10). 7 

Studies providing the cell culture results amongst RT-PCR positive respiratory samples were extracted to analyse the PPVs. The Rpackage meta (version 4.18-2) was used. 8 A random effects model was applied to calculate the pooled PPV with their 95% confidence interval (CI) (95%-CI). We estimated heterogeneity using τ 2 and Higgins inconsistency I 2 statistic and considered I 2 above 50% as high heterogeneity. 9 Subgroup analysis based on sampling time postsymptom onset was performed to explain heterogeneity. Based on the maximum duration of virus isolation in non-severe cases, which was reported as 9 days in the meta-analysis by Cevik et al., 3 following categories were used in sampling time subgroup analysis: early mixed (presymptomatic, 0-10 days, >10 days), within 10 days, late mixed (0-10 days, >10 days), beyond 10 days and not reported sampling time post-symptom-onset.

Studies with extractable Ct values or log 10 genome copies/ml and corresponding cell culture results were used to perform a logistic regression to estimate the probability of a positive culture depending on Ct value or log 10 genome copies/ml. To allow visual comparability of the plots, the extracted raw data from individual studies were plotted in a common coordinate. Virus isolation probabilities were estimated at Ct values and log 10 genome copies/ml which have been reported to be associated with nonviable virus (Ct value of 30 and 5 log 10 ). For clarity reasons CI band of each study is provided separately in the supplementary material (S13-32).

The database search identified 8939 references and 2 additional records from additional sources. After deduplication, 6219 records remained, of which 6074 were excluded during title and abstract screening ( Figure 1 ). One hundred and fourty five full texts were screened for eligibility and 55 studies were eligible, 53 peerreviewed articles 10-51,52-55,56-65 and 2 preprints. 66,67

A summary of characteristics of included studies is provided in 

Most studies providing data for diagnostic accuracy assessment showed high risk of bias (Summary table S5a, individual assessment S6). This judgement was mainly based on lack of blinding when conducting the 'reference standard' [14] [15] [16] [17] [18] [19] [20] and lack of inclusion of all samples when performing cell culture 14, 17, 20 or the studies did not report whether there was a 'sample processing delay' before inoculation of clinical specimen. 15, 16, [18] [19] [20] Studies which were included for PPV assessment (Summary table S5b, individual assessment S7) were most frequently assessed as high risk of bias in the domains 'patients selection' (22 out of 48 were scored high risk) and 'flow and timing' (32 out of 48 were scored high risk). Most of the studies were observational, thus patient selection was not random and inclusion and exclusion criteria were often unclear or not defined at all. 'Flow and timing' item was most commonly affected by the fact that not all patient samples underwent cell culture.

Sensitivity ranged from 90% to 99% and specificity ranged from 29% to 92%. Specificity varied across studies ( Figure 2 ) and the chi-square test suggested heterogeneity for specificities p < 0.001, while p = 0.794 was obtained for the test for equality of sensitivities.

Forest plots (Figure 2 ) demonstrate greater variability of specificities compared to sensitivities and ROC ellipses (S11) showed a greater coverage of prediction regions of specificity than of sensitivity. As sample sizes of sensitivities were smaller than that of specificities (S8), the variability of specificities most likely arises from heterogeneity and not random error. Based on the paucity of studies for sensitivity (n = 5) and the limitation of the included studies with heterogeneity of index tests, reference standards, study population, no meta-analysis of accuracy measurements could be performed.

A total of 9489 SARS-CoV-2 RT-PCR-positive respiratory samples were included.

Subgroup analyses were performed based on sampling time postsymptom onset (Figure 3 ). There was significant between-study heterogeneity (I 2 = 94%, τ 2 = 2.1; p < 0.01).

The PPV was 45% (CI, 26%-65%, six studies) in the subgroup The sensitivity analysis excluding studies at high risk of bias included 10 studies with unclear risk of bias and provided results comparable to those obtained from all studies (S12).

We included 13 studies for estimation of virus isolation probability depending on cycle threshold (N = 9) or log 10 genome copies/ml (n = 4) with sampling size ranging from 33 65 Virus isolation probability estimation across the studies at Ct value of 30 and at 5 log 10 genome copies/ml ranged for Ct from 6%

(CI, 0%-100%) 13 to 50% (CI, 0%-100%) 12 and for log 10 genome copies/ml from 0% (CI, 0%-22%) 45 to 63% (CI, 0%-100%) 12 ( Figure 4a,b) . As demonstrated by the 95% CI bands (S13-32) of the probability estimates the data has a high degree of uncertainty. The sensitivity was generally adequate, with no false negative results obtained in any of the studies; the lowest estimate of 90% was due to the continuity correction and small sample size. 17 This emphasises the importance of RT-PCR to rule out infectivity, provided that samples were collected and handled properly, and no gene dropout due to target gene mutations had occurred. 68 The specificity of RT-PCR to detect infectious samples varied considerably amongst the studies. Optimization of specificity would have been possible by ROC curve analysis, but only one study provided raw data that could be used to generate sensitivity and specificity values per Ct cut-off point. 16 The majority of the studies compared Ct or log 10 genome copies/ ml and cell culture results only from RT-PCR positive samples. For this reason no valid ROC analysis based on sensitivity and specificity was possible. We performed a logistic regression and estimated the probability of virus isolation at a relatively high Ct value of 30, but the estimates obtained precluded this Ct value as a cut-off for excluding infectivity.

In the meta-analysis by Cevik et al. a maximum virus isolation time of 9 days after symptom onset was shown for non-severe courses of the disease. 3 To quantify PPV, we performed subgroup analyses based on this sampling time after symptom onset.

Despite the large heterogeneity, the pooled PPV of 45% reflects that a substantial proportion of RT-PCR-positive samples do not result in detection of infectious virus within first 10 days of sampling.

The PPV of 1% in samples beyond 10 days supports the observation of prolonged RNA excretion even when no virus can be isolated. 3, 69 The high degree of heterogeneity among the studies might be due to different study designs, heterogenous populations studied at different time points, use of different respiratory specimen, variable permissiveness of cell lines and culture conditions and disparate RT-PCR standards.

Considering cell culture as a biological, that is Several factors that influence RT-PCR limits of detection and Ct values have been described, including pre-analytic factors like sample type and matrix, its collection, storage and preparation, and analytic factors like reagents of RT-PCR assay (primer sets, buffers, and enzymes, nucleic acid extraction efficiency, reference material of standard curve). [72] [73] [74] As shown in Figure 4 , a high degree of variability in the corre- 

This systematic review identified an evidence gap in well designed diagnostic accuracy studies comparing RT-PCR with cell culture as a surrogate for infectivity of SARS-CoV-2 patients. Such studies would provide essential information for clinical practice, where the differentiation between infectious and not infectious patients is highly important for clinical management.

Furthermore, we found a high degree of between study heterogeneity and a lack of standardisation especially of cell culture methodology.

However, it was possible to make rough estimations on the correlation between viral load measured by RT-PCR and infectivity based on these studies.

Taking into account that the studies were performed in different waves of the ongoing SARS-CoV-2 pandemic, these shortcomings are comprehensible, but have to be addressed in future research and pandemic management planing. Open access funding enabled and organized by Projekt DEAL.

The authors have no relevant competing interest to disclose in relation to this work.

No ethical approval is needed as systematic reviewing is based on published trial results. 

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0002-4091-2747

Diagnostic Testing for SARS-CoV-2

Misinterpretation of viral load in COVID-19 clinical outcomes

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Role of cell culture for virus detection in the age of technology

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing

Meta-Analysis of Diagnostic Accuracy

How to perform a meta-analysis with R: a practical tutorial

Measuring inconsistency in meta-analyses

Environmental and aerosolized SARS-CoV-2 among hospitalized COVID-19 patients

Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells

The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro

Duration of culturable SARS-CoV-2 in hospitalized patients with covid-19

Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses -Wisconsin

Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019-2020 in Parma, Northern Italy

High-speed large-scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled to high-content screening. Clinical microbiology and infection

Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses

An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA

Infectivity of healthcare workers diagnosed with SARS-CoV-2 infection approximately 2 weeks after onset of symptoms: a cross-sectional study

Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture

Repeat COVID-19 molecular testing: correlation of SARS-CoV-2 culture with molecular assays and cycle thresholds

Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility

Investigation of SARS-CoV-2 outbreaks in six care homes in London

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19

Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults

Shedding of culturable virus, seroconversion, and 6-month follow-up antibody responses in the first 14 confirmed cases of COVID-19 in the United States

Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States

Culturecompetent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents

Consistent detection of 2019 novel coronavirus in saliva

Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer

Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19

Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England

Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing

Predicting infectious SARS-CoV-2 from diagnostic samples

Persistent SARS-CoV-2 replication in severe COVID-19

Culture-based virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19

Clinical evaluation of Roche SD biosensor rapid antigen test for SARS-CoV-2 in municipal health service testing site, The Netherlands

Viable SARS-CoV-2 in various specimens from COVID-19 patients

Finding from Investigation and Analysis of Re-positive Cases

Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals

SARS-CoV-2 virus culture and subgenomic RNA for respiratory specimens from patients with mild coronavirus disease

Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study

Evaluation of abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection at two community-based testing sites -Pima county

Infectious period of severe acute respiratory syndrome coronavirus 2 in 17 nursing home residents-Arkansas

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series

Virological assessment of hospitalized patients with COVID-2019

Comparison of rapid antigen tests for COVID-19

Viral dynamics and immune correlates of COVID-19 disease severity

Persistent viral presence determines the clinical course of the disease in COVID-19

Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR

Real time PCR and culturebased virus isolation test in clinically recovered patients: is the subject still infectious for SARS-CoV2?

Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19

Assessing viral shedding and infectivity of asymptomatic or mildly symptomatic patients with COVID-19 in a later phase

Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates

SARS-CoV-2 infection of the oral cavity and saliva

Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19: is prolonged quarantine always justified?

A generic, scalable, and rapid time-resolved förster resonance energy transfer-based assay for antigen detection-SARS-CoV-2 as a proof of concept. mBio

An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value

Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community

Performance of a point-of-care test for the rapid detection of SARS-CoV-2 antigen

Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread?

Iscontinuation of isolation for persons with COVID-19: is 10 days really safe? MedRxiv

Re-positive discharged COVID-19 patients are at low transmission risk for SARS-CoV-2 infection-a finding from recovered COVID-19 patients in Wuhan, China. Research Square

SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay

Viral cultures for coronavirus disease 2019 infectivity assessment: a systematic review

SARScoronavirus-2 replication in Vero E6 cells: replication kinetics

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics

RT-PCR for SARS-CoV-2: quantitative versus qualitative

Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection

A roadmap to better COVID-19 testing from the coronavirus standards working group

The truth about SARS-CoV-2 cycle threshold values is rarely pure and never simple

Infection with the SARS-CoV-2 delta variant is associated with higher recovery of infectious virus compared to the alpha variant in both unvaccinated and vaccinated individuals

Additional supporting information can be found online in the Supporting Information section at the end of this article.